Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
NCT07721090
Bacterial Infections and Mycoses, Behavior
View Trial DetailsNCT Number: NCT07597616
This case-control study will enroll 176 patients age- and sex- matched at the Oral Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome. There will be two groups: The control group will consist of 88 healthy patients enrolled among those routinely attending the dental outpatient clinic. An additional 88 patients diagnosed with OLP will form the case group. Both groups will undergo standard dental examinations, including periodontal probing. The primary objective is to evaluate whether patients with OLP present a higher prevalence and severity of periodontitis compared to healthy subjects. Secondary objectives include the assessment of gingivitis prevalence and RT1 gingival recessions in OLP patients compared with controls. Periodontal status will be assessed using major clinical indices and classified according to the 2017 AAP/EFP case definition. The study aims to contribute evidence on the shared immune-inflammatory mechanisms underlying both conditions, with potential clinical implications for the integrated periodontal management of OLP patients.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age ≥ 18 years Clinical and histopathological diagnosis of OLP according to WHO criteria (2021)
Control group
Age ≥ 18 years Absence of clinical signs of OLP
Exclusion criteria
Oral lichenoid lesions (OLL): oral lichenoid contact reactions (OLCR), lichenoid drug reactions (LDR), lesions associated with food/substances (e.g. cinnamon) Oral lesions associated with graft-versus-host disease (GVHD) History of haematopoietic stem cell transplantation (HSCT) Pregnancy Oncologic patients (including oral cancers) Smokers Diabetes mellitus Obesity Metabolic syndrome Immunosuppressive therapy Medications causing gingival hyperplasia
Control group only
Immune-mediated inflammatory diseases with oral involvement (e.g. psoriasis, systemic or discoid lupus erythematosus) Autoimmune oral diseases other than OLP
OLP group only
Immunosuppressive therapy for conditions other than OLP Autoimmune oral diseases other than OLP
Time frame: From 20 of May to 15 of June
Catholic University of the Sacred Heart
Other
Studio Retrospettivo Monocentrico di Una Coorte di Pazienti Affetti da Lichen Planus Orale: Caratteristiche, comorbilità e Fattori di Rischio Per la Trasformazione Maligna
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07721090
Bacterial Infections and Mycoses, Behavior
View Trial DetailsNCT06876038
Carcinoma, Carcinoma in Situ
Ernākulam, Kerala, India
View Trial DetailsNCT07381595
Lichen Planus, Lichen Planus, Oral
Rohtak, Haryana, India
View Trial DetailsNCT07280442
Lichen Planus, Lichen Planus, Oral
Madrid, Spain
View Trial Details